Side-by-side comparison of AI visibility scores, market position, and capabilities
Ludwigshafen global chemical leader (XETRA: BASF) at €70.4B 2024 revenue; €8.7B Zhanjiang China Verbund site production commenced (renewable electricity 2025) with CEO Kamieth transformation competing with Dow for global chemical leadership.
BASF SE is a Ludwigshafen, Germany-headquartered global chemical company — publicly traded on Deutsche Börse Xetra (XETRA: BASF) and the Frankfurt Stock Exchange — operating as the world's largest chemical producer with €70.4 billion in 2024 revenue and 111,822 employees across operations in 80+ countries through six integrated Verbund production sites and 390+ additional sites on six continents. In 2024-2025, BASF commenced production at its €8.7 billion Zhanjiang Verbund site in China — the company's largest-ever single investment and seventh Verbund site — which will operate on 100% renewable electricity starting 2025. CEO Markus Kamieth has led BASF since April 2024, executing a strategic transformation to differentiate core businesses and pursue €4 billion in renewable energy investment by 2030 toward a net-zero CO2 emissions target by 2050. BASF's six business segments are Chemicals, Materials, Industrial Solutions, Nutrition & Care, Surface Technologies, and Agricultural Solutions. Founded 1865 as Badische Anilin- und Sodafabrik in Mannheim, Germany.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.